BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15362516)

  • 1. [Effect of injection of testosterone undecanoate and depot medroxyprogesterone acetate on the suppression of spermatogenesis].
    Tang W; Gu Y; Tong J; Ma D; Wang X; Yuan D; Chen Z; Bremner WJ
    Zhonghua Nan Ke Xue; 2004 Aug; 10(8):572-7, 581. PubMed ID: 15362516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Male hormonal contraception: effects of injections of testosterone undecanoate and depot medroxyprogesterone acetate at eight-week intervals in chinese men.
    Gu YQ; Tong JS; Ma DZ; Wang XH; Yuan D; Tang WH; Bremner WJ
    J Clin Endocrinol Metab; 2004 May; 89(5):2254-62. PubMed ID: 15126550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intramuscular testosterone enanthate plus very low dosage oral levonorgestrel suppresses spermatogenesis without causing weight gain in normal young men: a randomized clinical trial.
    Anawalt BD; Amory JK; Herbst KL; Coviello AD; Page ST; Bremner WJ; Matsumoto AM
    J Androl; 2005; 26(3):405-13. PubMed ID: 15867009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men.
    Gu YQ; Wang XH; Xu D; Peng L; Cheng LF; Huang MK; Huang ZJ; Zhang GY
    J Clin Endocrinol Metab; 2003 Feb; 88(2):562-8. PubMed ID: 12574181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of rat germ cell apoptosis by testosterone undecanoate and depot medroxyprogesterone acetate and correlation of apoptotic cells with sperm concentration.
    Ilyas S; Lestari SW; Moeloek N; Asmarinah ; Siregar NC
    Acta Med Indones; 2013 Jan; 45(1):32-7. PubMed ID: 23585406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of spermatogenesis by testosterone enanthate in Thai men.
    Aribarg A; Sukcharoen N; Chanprasit Y; Ngeamvijawat J; Kriangsinyos R
    J Med Assoc Thai; 1996 Oct; 79(10):624-9. PubMed ID: 8996996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible azoospermia induced by an androgen-progestin combination regimen in Indonesian men.
    Pangkahila W
    Int J Androl; 1991 Aug; 14(4):248-56. PubMed ID: 1831798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal contraception in Chinese men: variations in suppression of spermatogenesis with injectable testosterone undecanoate and levonorgestrel implants.
    Liu ST; Gui YL; Lin CH; He CH
    Asian J Androl; 2004 Mar; 6(1):41-6. PubMed ID: 15064833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception.
    Kamischke A; Venherm S; Plöger D; von Eckardstein S; Nieschlag E
    J Clin Endocrinol Metab; 2001 Jan; 86(1):303-9. PubMed ID: 11232016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A lower dosage levonorgestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotropin levels with fewer metabolic effects than higher dosage combinations.
    Anawalt BD; Bebb RA; Bremner WJ; Matsumoto AM
    J Androl; 1999; 20(3):407-14. PubMed ID: 10386821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of testosterone undecanoate injected alone or in combination with norethisterone enanthate in healthy men.
    Qoubaitary A; Meriggiola C; Ng CM; Lumbreras L; Cerpolini S; Pelusi G; Christensen PD; Hull L; Swerdloff RS; Wang C
    J Androl; 2006; 27(6):853-67. PubMed ID: 16837736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trials for development of once-a-month injectable, hormonal male contraceptive using dienogest plus testosterone undecanoate: dose standardization, efficacy and reversibility studies in rats.
    Misro MM; Chaki SP; Kaushik MC; Nandan D
    Contraception; 2009 Jun; 79(6):488-97. PubMed ID: 19442786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors for partial suppression of spermatogenesis of hormonal male contraception.
    Li JW; Gu YQ
    Asian J Androl; 2008 Sep; 10(5):723-30. PubMed ID: 18645675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist.
    Page ST; Amory JK; Anawalt BD; Irwig MS; Brockenbrough AT; Matsumoto AM; Bremner WJ
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4374-80. PubMed ID: 16940442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Male hormonal contraception: suppression of spermatogenesis by injectable testosterone undecanoate alone or with levonorgestrel implants in chinese men.
    Gui YL; He CH; Amory JK; Bremner WJ; Zheng EX; Yang J; Yang PJ; Gao ES
    J Androl; 2004; 25(5):720-7. PubMed ID: 15292101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of MPA and MPA + TU on the rat spermatogenesis and sexual hormones].
    Jia Y; Cui YG; Wang XH; Tong JS; Ma DZ; Cai RF; Di FS; Sha JH
    Zhonghua Nan Ke Xue; 2002; 8(2):109-11. PubMed ID: 12479022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible effect of testosterone undecanoate injection on spermatogenesis in rats.
    Wen XH; Wang XH; Tong JS; Yang ZW; Zhang GY
    Asian J Androl; 2000 Sep; 2(3):207-11. PubMed ID: 11225979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone undecanoate maintains spermatogenic suppression induced by cyproterone acetate plus testosterone undecanoate in normal men.
    Meriggiola MC; Costantino A; Cerpolini S; Bremner WJ; Huebler D; Morselli-Labate AM; Kirsch B; Bertaccini A; Pelusi C; Pelusi G
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5818-26. PubMed ID: 14671175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations.
    Kamischke A; Heuermann T; Krüger K; von Eckardstein S; Schellschmidt I; Rübig A; Nieschlag E
    J Clin Endocrinol Metab; 2002 Feb; 87(2):530-9. PubMed ID: 11836281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.